191 related articles for article (PubMed ID: 25310988)
1. VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobilization.
Lim S; Zhang Y; Zhang D; Chen F; Hosaka K; Feng N; Seki T; Andersson P; Li J; Zang J; Sun B; Cao Y
Cell Rep; 2014 Oct; 9(2):569-80. PubMed ID: 25310988
[TBL] [Abstract][Full Text] [Related]
2. The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia.
Amano H; Kato S; Ito Y; Eshima K; Ogawa F; Takahashi R; Sekiguchi K; Tamaki H; Sakagami H; Shibuya M; Majima M
PLoS One; 2015; 10(7):e0131445. PubMed ID: 26133989
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor 1 (VEGFR1) tyrosine kinase signaling facilitates granulation tissue formation with recruitment of VEGFR1
Park K; Amano H; Ito Y; Mastui Y; Kamata M; Yamazaki Y; Takeda A; Shibuya M; Majima M
Anat Sci Int; 2018 Jun; 93(3):372-383. PubMed ID: 29256114
[TBL] [Abstract][Full Text] [Related]
4. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells.
Barthelmes D; Irhimeh MR; Gillies MC; Karimipour M; Zhou M; Zhu L; Shen WY
Blood Cells Mol Dis; 2013 Oct; 51(3):163-73. PubMed ID: 23714230
[TBL] [Abstract][Full Text] [Related]
5. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
Hiratsuka S; Nakao K; Nakamura K; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):346-54. PubMed ID: 15601855
[TBL] [Abstract][Full Text] [Related]
6. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
7. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
[TBL] [Abstract][Full Text] [Related]
8. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos.
Hiratsuka S; Kataoka Y; Nakao K; Nakamura K; Morikawa S; Tanaka S; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):355-63. PubMed ID: 15601856
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
J Immunol; 2005 Jan; 174(1):215-22. PubMed ID: 15611243
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK
Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585
[TBL] [Abstract][Full Text] [Related]
12. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of β1-integrin in progenitor cell migration and adhesion.
Nelson J; Wu Y; Jiang X; Berretta R; Houser S; Choi E; Wang J; Huang J; Yang X; Wang H
FASEB J; 2015 Jul; 29(7):3085-99. PubMed ID: 25854700
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells.
Ulyatt C; Walker J; Ponnambalam S
Biochem Biophys Res Commun; 2011 Jan; 404(3):774-9. PubMed ID: 21168388
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
16. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors.
Rafii S; Heissig B; Hattori K
Gene Ther; 2002 May; 9(10):631-41. PubMed ID: 12032709
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth.
Wicki A; Rochlitz C; Orleth A; Ritschard R; Albrecht I; Herrmann R; Christofori G; Mamot C
Clin Cancer Res; 2012 Jan; 18(2):454-64. PubMed ID: 22065082
[TBL] [Abstract][Full Text] [Related]
18. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway.
Liu W; Xu J; Wang M; Wang Q; Bi Y; Han M
Int J Oncol; 2011 Nov; 39(5):1213-20. PubMed ID: 21785819
[TBL] [Abstract][Full Text] [Related]
20. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
